Health ❯ Pharmaceuticals

Drug Pricing

Market Dynamics Market Competition Weight Loss Drugs Medicare Novo Nordisk Ozempic and Wegovy Government Policy Tariffs Healthcare Policy Mounjaro

Trump Promotes Mystery 'Freedom Fuel' Network Selling Below‑Market Gas

Opaque ownership and likely unsustainable pricing make the promotion a political gambit with limited market impact.

U.S. Opens Section 301 Probe Into Germany's Drug Pricing

Senate Bill Would Require Drugmakers to Share FDA Filings and Bar Patent Enforcement

UK Pharmacies Lift Prices Up to 30% as Iran War Disrupts Drug Supplies

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

Brazil Sets 2026 Medicine Price Caps With Three-Tier Increases Up to 3.81%

Trump Unveils TrumpRx Drug-Discount Portal as State Department Plans MAGA-Aligned Funding in Europe

U.S. and U.K. Strike Preliminary Deal Trading Tariff Relief for Higher NHS Drug Prices

US‑UK Deal Shields British Pharma From Tariffs for Three Years

WHO Endorses GLP‑1s for Obesity as Australia Adds Class‑Wide Mental Health Warning

Novo Nordisk Lowers Wegovy and Ozempic Cash Price to $349 and Unveils $199 Starter Offer

Germany Launches Pharma and MedTech Strategy Talks to Tackle Drug Shortages

White House Strikes Deals With Lilly and Novo to Cut GLP-1 Prices, Widen Medicare Access

Shutdown Reaches Day 36 as FAA Orders Flight Cuts and Markets Whipsaw

U.S. Envoy Warns of Pharma Pullout as AstraZeneca Rejects UK Drug-Price Offer

Kennedy Says Evidence Is Not Sufficient to Link Tylenol to Autism

Lilly Taps Walmart for First Retail Pickup of Discounted Zepbound Vials Starting Mid-November

TrumpRx–Pfizer Drug-Price Deal Leaves Key Details Unclear

Amgen Launches AmgenNow to Sell Repatha Direct to U.S. Patients at $239 a Month

Trump Unveils New Tariffs on Branded Drugs, Trucks and Furniture With Trade-Deal Carve-Outs